Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Avenida Plaza 680, Las Condes, Kinesiología, Santiago de, Chile.
Hospital del Salvador, Servicio de Medicina Física y Rehabilitación, Santiago de, Chile.
BMC Gastroenterol. 2023 Oct 9;23(1):352. doi: 10.1186/s12876-023-02970-6.
Bowel complaints are very common among patients with colorectal cancer. However, the most used questionnaires for colorectal cancer survivors do not comprehensively comprise bowel symptoms. This study aimed to examine construct and criterion validity, as well as internal consistency, of the Chilean Version of the International Consultation on Incontinence Questionnaire Bowel Module (ICIQ-B) among people with colorectal cancer.
Cross-sectional, validation study performed with 106 colorectal cancer patients from Hospital del Salvador, Chile. Bowel function was assessed with the ICIQ-B. Construct validity was assessed with confirmatory factor analysis and hypothesis testing. Specific items of a quality-of-life questionnaire (EORTC QLQ-CR29) were used to correlate with similar ICIQ-B items for criterion validity. For internal consistency, Cronbach's alpha was computed.
For construct validity, the confirmatory factor analysis showed that the three factors model did not fit our data. Meanwhile, hypothesis testing favored the construct validity of the instrument, considering that rectal cancer patients showed worse bowel pattern (p = 0.001), bowel control (p = 0.001) and quality of life (p < 0.001) scores compared to colon cancer patients. In addition, those patients assessed before surgery also presented worse scores bowel control (p = 0.023) and quality of life (p = 0.009) compared to post-surgical patients. Regarding criterion validity, the ICIQ-B items showed a significant correlation with similar QLQ-CR29 items. The internal reliability of the instrument was good (Cronbach's α = 0.909).
Considering that this questionnaire appraises bowel function in more depth, it is recommended for use in clinical practice and research with colorectal cancer patients.
结直肠癌患者常出现肠道不适症状。然而,最常用于结直肠癌幸存者的问卷并不能全面涵盖肠道症状。本研究旨在检验智利版国际尿失禁咨询问卷肠道模块(ICIQ-B)在结直肠癌患者中的结构和效标效度,以及内部一致性。
这是一项在智利萨尔瓦多医院进行的横断面验证性研究,共纳入 106 例结直肠癌患者。采用 ICIQ-B 评估肠道功能。采用验证性因子分析和假设检验评估结构效度。使用特定的生活质量问卷(EORTC QLQ-CR29)项目与 ICIQ-B 中相似的项目进行关联,以评估效标效度。采用 Cronbach's alpha 评估内部一致性。
结构效度方面,验证性因子分析表明三因素模型不适合我们的数据。同时,假设检验也支持该工具的结构效度,因为直肠癌患者在肠道模式(p=0.001)、肠道控制(p=0.001)和生活质量(p<0.001)方面的评分均较差,与结肠癌患者相比。此外,与术后患者相比,术前评估的患者在肠道控制(p=0.023)和生活质量(p=0.009)方面的评分也较差。在效标效度方面,ICIQ-B 项目与相似的 QLQ-CR29 项目具有显著相关性。该工具的内部可靠性良好(Cronbach's α=0.909)。
鉴于该问卷更深入地评估了肠道功能,建议在结直肠癌患者的临床实践和研究中使用。